Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
7 Views
administrator
08/09/23
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
-
Category
Show more
Facebook Comments
No comments found